John Mykytiuk

Title: John Mykytiuk: Innovator in Pharmaceutical Chemistry

Introduction

John Mykytiuk is a notable inventor based in Houghton le Spring, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new therapeutic agents. His work focuses on innovative compounds that have the potential to improve treatment options for various diseases.

Latest Patents

John Mykytiuk holds a patent for "Crystalline forms of pyrimidino diazepine derivative." This invention relates to new crystalline forms of a pyrimido-diazepine derivative that exhibits excellent anti-tumour activity. The patent also covers a pharmaceutical composition containing these crystalline forms as an active ingredient, along with their use in the prevention or treatment of disease. Furthermore, the invention details a process for preparing these crystalline forms.

Career Highlights

Mykytiuk is currently associated with Cyclacel Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new treatments that could potentially benefit patients suffering from various conditions.

Collaborations

Throughout his career, John has collaborated with several professionals in the field, including Benjamin Skead and Julian Northen. These collaborations have fostered a productive environment for innovation and research.

Conclusion

John Mykytiuk is a dedicated inventor whose work in pharmaceutical chemistry has the potential to make a significant impact on healthcare. His innovative approaches to drug development highlight the importance of research in creating effective treatments for diseases.